In summary, we have demonstrated that geridonin and paclitaxel act synergistically to suppress the growth of gastric cancer cells both in vitro and in vivo through ROS-mediated PTEN activation and deactivation of the PI3K/Akt signaling pathway. Here, AKT1 is linked to gastric cancer.